Precision Neuroscience Raises $250 Million Series D To Advance Brain-Computer Interface Technology
By Amit Chowdhry ● Today at 7:35 AM
Precision Neuroscience has raised $250 million in an oversubscribed Series D financing, bringing its total funding to $430 million as it advances its brain-computer interface technology toward broader clinical use and commercialization. The round was co-led by Pershing Square Inc., the Ackman Oxman Institute, and an undisclosed life sciences investment fund. Additional investors included Duquesne Family Office, B Capital, ARK Invest, Invus, Mubadala Capital, Mirae Asset Capital, Korea Investment Partners, Hitachi Ventures, and JSL Health Capital.